79 patents
Page 3 of 4
Utility
Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
16 Feb 21
Nicolas Luc Sabourault, Piet Wigernick
Filed: 30 Sep 19
Utility
Prodrug Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
2 Dec 20
The present invention relates to prodrug compounds and their use in the treatment of Cystic Fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.
Didier Philippe Robert Schils, Sam Bob Corveleyn, Herman Augustinus De Kock, Matthew Beau Dufek
Filed: 1 Jun 20
Utility
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
23 Nov 20
Robert J. Altenbach, Andrew Bogdan, Sylvain Couty, Nicolas Desroy, Gregory A. Gfesser, Christopher Gaëtan Housseman, Philip R. Kym, Bo Liu, Thi Thu Trang Mai, Karine Fabienne Malagu, Nuria Merayo Merayo, Olivier Laurent Picolet, Mathieu Rafaël Pizzonero, Xenia B. Searle, Steven Emiel Van der Plas, Xueqing Wang, Ming C. Yeung
Filed: 18 May 20
Utility
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
23 Nov 20
Robert J. Altenbach, Andrew Bogdan, Sylvain Couty, Nicolas Desroy, Gregory A. Gfesser, Christopher Gaëtan Housseman, Philip R. Kym, Bo Liu, Thi Thu Trang Mai, Karine Fabienne Malagu, Nuria Merayo Merayo, Olivier Laurent Picolet, Mathieu Rafaël Pizzonero, Xenia B. Searle, Steven Emiel Van der Plas, Xueqing Wang, Ming C. Yeung
Filed: 18 May 20
Utility
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
9 Nov 20
Robert J. Altenbach, Andrew Bogdan, Sylvain Couty, Nicolas Desroy, Gregory A. Gfesser, Christopher Gaëtan Housseman, Philip R. Kym, Bo Liu, Thi Thu Trang Mai, Karine Fabienne Malagu, Nuria Merayo Merayo, Olivier Laurent Picolet, Mathieu Rafaël Pizzonero, Xenia B. Searle, Steven Emiel Van der Plas, Xueqing Wang, Ming C. Yeung
Filed: 18 May 20
Utility
5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritis
9 Nov 20
Frédéric Gilbert Labéguère, Rama Heng, Frédéric André De Ceuninck, Luke Jonathan Alvey, David Amantini, Franck Laurent Brebion, Pierre Marc Marie Joseph Deprez, Romain Luc Marie Gosmini, Hélène Marie Jary, Christophe Peixoto, Iuliana Ecaterina Pop-Botez, Marie Laurence Claire Varin
Filed: 31 May 17
Utility
Antagonists of IL17C for the treatment of inflammatory disorders
26 Oct 20
The present invention provides antagonists of IL17C for use in the treatment of an inflammatory disorder.
Andreas Bültmann, Robert Mühlbacher, Teresa Garcia, Reginald Christophe Xavier Brys, Luc Nelles, Katja Conrath
Filed: 7 Nov 18
Utility
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
2 Sep 20
Robert J. Altenbach, Andrew Bogdan, Sylvain Couty, Nicolas Desroy, Gregory A. Gfesser, Christopher Gaëtan Housseman, Philip R. Kym, Bo Liu, Thi Thu Trang Mai, Karine Fabienne Malagu, Nuria Merayo Merayo, Olivier Laurent Picolet, Mathieu Rafaël Pizzonero, Xenia B. Searle, Steven Emiel Van der Plas, Xueqing Wang, Ming C. Yeung
Filed: 18 May 20
Utility
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
2 Sep 20
Robert J. Altenbach, Andrew Bogdan, Sylvain Couty, Nicolas Desroy, Gregory A. Gfesser, Christopher Gaëtan Housseman, Philip R. Kym, Bo Liu, Thi Thu Trang Mai, Karine Fabienne Malagu, Nuria Merayo Merayo, Olivier Laurent Picolet, Mathieu Rafaël Pizzonero, Xenia B. Searle, Steven Emiel Van der Plas, Xueqing Wang, Ming C. Yeung
Filed: 18 May 20
Utility
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
2 Sep 20
Robert J. Altenbach, Andrew Bogdan, Sylvain Couty, Nicolas Desroy, Gregory A. Gfesser, Christopher Gaëtan Housseman, Philip R. Kym, Bo Liu, Thi Thu Trang Mai, Karine Fabienne Malagu, Nuria Merayo Merayo, Olivier Laurent Picolet, Mathieu Rafaël Pizzonero, Xenia B. Searle, Steven Emiel Van der Plas, Xueqing Wang, Ming C. Yeung
Filed: 18 May 20
Utility
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
2 Sep 20
Robert J. Altenbach, Andrew Bogdan, Sylvain Couty, Nicolas Desroy, Gregory A. Gfesser, Christopher Gaëtan Housseman, Philip R. Kym, Bo Liu, Thi Thu Trang Mai, Karine Fabienne Malagu, Nuria Merayo Merayo, Olivier Laurent Picolet, Mathieu Rafaël Pizzonero, Xenia B. Searle, Steven Emiel Van der Plas, Xueqing Wang, Ming C. Yeung
Filed: 18 May 20
Utility
Compounds and Pharmaceutical Compositions Thereof for Use In the Treatment of Fibrotic Diseases
12 Aug 20
The present invention relates to the use of the compound according to Formula I in the prophylaxis and/or treatment of fibrotic diseases, more particularly idiopathic pulmonary fibrosis.
Elisabeth Martina VAN DER AAR, Olivier Frans Jozef Maria VAN DE STEEN
Filed: 7 Aug 18
Utility
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
29 Jul 20
Nicolas DESROY, Bertrand HECKMANN, Reginald Christophe Xavier BRYS, Agnès Marie JONCOUR, Christophe PEIXOTO, Xavier Marie BOCK
Filed: 12 Nov 19
Utility
Novel Salts and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
29 Jul 20
Nicolas Luc SABOURAULT, Carla DE FAVERI, Ahmad SHEIKH
Filed: 29 Sep 19
Utility
5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE Derivatives As Adamts Inhibitors for the Treatment of Osteoarthritis
8 Jul 20
Franck Laurent BREBION, Luke Jonathan ALVEY, David AMANTINI, Frédéric André DE CEUNINCK, Pierre Marc Marie Joseph DEPREZ, Romain Luc Marie GOSMINI, Hélène Marie JARY, Christophe PEIXOTO, Iuliana Ecaterina POP-BOTEZ, Marie Laurence Claire VARIN
Filed: 14 Oct 19
Utility
Antibodies for IL-17C
8 Jul 20
The present invention provides antibodies or antibody fragments binding to human IL-17C.
Jan Dominik HAAS, Jürgen KLATTIG, Nick Ernest René VANDEGHINSTE
Filed: 17 Mar 20
Utility
Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
6 Jul 20
Piet Wigerinck, Nicolas Luc Sabourault
Filed: 9 Jul 17
Utility
Pyrrolopyrimidine and Pyrrolopyridine Derivatives
27 May 20
David AMANTINI, Milan MESIC, Gordon SAXTY, Tanja POLJAK, Ines VUJASINOVIC, Dinko ZIHER, David WITTY, Karl Richard GIBSON
Filed: 11 Jul 18
Utility
N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
11 May 20
Rhalid Akkari, Luke Jonathan Alvey, Xavier Marie Bock, Brian S. Brown, Pieter Isabelle Roger Claes, Marlon D. Cowart, Elsa De Lemos, Nicolas Desroy, Béranger Duthion, Gregory A. Gfesser, Romain Luc Marie Gosmini, Christopher Gaëtan Housseman, Koen Karel Jansen, Jianguo Ji, Philip R. Kym, Jean-Michel Lefrancois, Oscar Mammoliti, Christel Jeanne Marie Menet, Nuria Merayo Merayo, Gregory John Robert Newsome, Adeline Marie Elise Palisse, Sachin V. Patel, Matthieu Rafaël Pizzonero, Anurupa Shrestha, Elizabeth C. Swift, Steven Emiel Van der Plas, Xueqing Wang, Ann de Blieck
Filed: 17 Jun 19
Utility
Antibodies for IL-17C
27 Apr 20
The present invention provides antibodies or antibody fragments binding to human IL-17C.
Jan Dominik Haas, Jürgen Klattig, Nick Ernest Rene Vandeghinste
Filed: 25 Feb 19